Skip to main content
. 2026 Oct 10;15(5):95. doi: 10.3390/antib15050095
MN Membranous nephropathy
MCD Minimal change disease
FSGS Focal segmental glomerulosclerosis
IgAN IgA nephropathy
MPGN Membranoproliferative glomerulonephritis
CR Complete remission
PR Partial remission
eGFR Estimated glomerular filtration rate
UPCR Urinary protein-to-creatinine ratio
NR Not reported
CS Corticosteroids
CNI Calcineurin inhibitors
MMF Mycophenolate mofetil
RTX Rituximab
F-U Follow-up